[Libreville, Gabon – 15 January 2023].
The Fondation Ma Bannière and the global pharmaceutical company Merck have announced a strategic partnership with the Center Hospitalier Universitaire de Libreville (CHUL) in Gabon to combat severe diseases. This collaboration will focus on enhancing healthcare skills and advancing medical research. Merck, a leader in global health, has a history of supporting public health initiatives.
The partnership aims to bolster healthcare services in Gabon by providing training for healthcare professionals and conducting research into effective treatments. Joint research efforts will also seek to develop innovative medical solutions. This partnership is anticipated to reduce the incidence and impact of severe diseases in Gabon, leading to improved health outcomes for the local population.
The agreement, signed recently, marks a significant milestone in Gabon’s healthcare landscape. A representative from the Fondation Ma Bannière expressed confidence in the collaboration’s potential: “This partnership will make a substantial impact on the health of Gabonese citizens. By pooling our resources and expertise, we are committed to combating severe diseases and enhancing the quality of life for all.”.
Source: Fondation Ma Bannière
